Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S W Yee

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Clinical Pharmacology and Therapeutics|December 27, 2012
The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metforminS L Stocker, K M Morrissey, S W Yee, et al.
Clinical Pharmacology and Therapeutics|May 24, 2014
Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metforminS Goswami, S W Yee, S Stocker, et al.
Clinical Pharmacology and Therapeutics|March 4, 2011
Functional characterization of liver enhancers that regulate drug-associated transportersM J Kim, P Skewes-Cox, H Fukushima, et al.
Clinical Pharmacology and Therapeutics|September 30, 2011
A common 5'-UTR variant in MATE2-K is associated with poor response to metforminJ H Choi, S W Yee, A H Ramirez, et al.
Clinical Pharmacology and Therapeutics|November 19, 2016
Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-AnalysisT Dujic, K Zhou, S W Yee, et al.
The Pharmacogenomics Journal|February 10, 2016
Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell linesA Chhibber, C E French, S W Yee, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Clinical Pharmacology and Therapeutics|December 27, 2012
The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metforminS L Stocker, K M Morrissey, S W Yee, et al.
Clinical Pharmacology and Therapeutics|May 24, 2014
Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metforminS Goswami, S W Yee, S Stocker, et al.
Clinical Pharmacology and Therapeutics|March 4, 2011
Functional characterization of liver enhancers that regulate drug-associated transportersM J Kim, P Skewes-Cox, H Fukushima, et al.
Clinical Pharmacology and Therapeutics|September 30, 2011
A common 5'-UTR variant in MATE2-K is associated with poor response to metforminJ H Choi, S W Yee, A H Ramirez, et al.
Clinical Pharmacology and Therapeutics|November 19, 2016
Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-AnalysisT Dujic, K Zhou, S W Yee, et al.
The Pharmacogenomics Journal|February 10, 2016
Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell linesA Chhibber, C E French, S W Yee, et al.
Pageof 3